Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » With Revenue Dwindling, LSBC Still Hopes to Market Chips in Early 2003

With Revenue Dwindling, LSBC Still Hopes to Market Chips in Early 2003

Feb 11, 2002
Premium

Despite cash-flow problems and the termination of its research partnership with antibody-manufacturer Biosite, Large Scale Biology still has plans to release antibody chips for use in commercial research by early 2003, LSBC CEO Bob Erwin told ProteoMonitor last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Extension Call

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

All Along the Axon

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

For the Accelerator

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

Science Papers Describe New Cas9 Variant, Atlas of Human Metabolism

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.

May
06
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Proteomics & Protein Research

  1. 10x Genomics Joins Single-Cell Multi-Omics Alliance to Develop Antibody Therapies for Coronavirus

  2. Proteomics Labs Exploring COVID-19 Therapeutic Options, Dx Development

  3. Affinity-Based Platforms Challenging Mass Spec for Protein Biomarker Discovery

    Premium

  4. IsoPlexis, Institute for Systems Biology Partner to Identify COVID-19 Immune Mechanisms

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.